article thumbnail

STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more

STAT

Novo Nordisk plans to seek coverage by Germany’s public health insurance scheme for the use of its Wegovy drug to cut the risk of strokes and heart attacks, if the extended indication wins European approval , Reuters notes.

article thumbnail

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

According to the World Health Organisation (WHO), an estimated two billion people across the world do not have access to essential medicines for life threatening diseases like cancer, AIDS and even autoimmune diseases like Type 1 diabetes.

article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

Up until now, the insulin market has experienced little competition and, as a result, prices have soared over the years. More than 30 million Americans have diabetes and another 88 million are at risk of developing it. One of these markets is the insulin market.